Engineers Gate Manager LP Pulmonx Corp Transaction History

Engineers Gate Manager LP

  • $4.86 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$5.77 - $9.82 $175,702 - $299,028
-30,451 Reduced 67.55%
14,628 $92,000
Q1 2024

May 15, 2024
BUY
$8.71 - $14.65 $165,455 - $278,291
18,996 Added 72.83%
45,079 $417,000
Q4 2023

Feb 14, 2024
BUY
$7.89 - $13.14 $52,870 - $88,051
6,701 Added 34.57%
26,083 $332,000
Q3 2023

Nov 14, 2023
BUY
$9.88 - $14.0 $191,494 - $271,348
19,382 New
19,382 $200,000
Q2 2022

Aug 15, 2022
BUY
$14.0 - $27.95 $202,230 - $403,737
14,445 New
14,445 $213,000

Others Institutions Holding LUNG

# of Institutions
123
Shares Held
31M
Call Options Held
300
Put Options Held
204K
View Full List

About Pulmonx Corp

LUNG Quotes by TradingView
  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $236M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email